Efg Asset Management (North America) Corp. Vertex Pharmaceuticals Inc Transaction History
Efg Asset Management (North America) Corp.
- $566 Million
- Q2 2024
A detailed history of Efg Asset Management (North America) Corp. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 8,439 shares of VRTX stock, worth $4.24 Million. This represents 0.7% of its overall portfolio holdings.
Number of Shares
8,439
Previous 7,301
15.59%
Holding current value
$4.24 Million
Previous $3.05 Million
29.63%
% of portfolio
0.7%
Previous 0.54%
Shares
9 transactions
Others Institutions Holding VRTX
# of Institutions
1,716Shares Held
225MCall Options Held
1.19MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA26.7MShares$13.4 Billion2.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA23MShares$11.5 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.7 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.7MShares$5.89 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA8.54MShares$4.29 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $129B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...